Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reardon

Showing results (371-380 of 558) with videos related to

Pageof 56
Sort By:
JACC. Case Reports|June 25, 2026
Redo Transcatheter Aortic Valve Replacement for Degenerated Valve With High-Risk Coronary AnatomyChloe Kharsa, Gal Sella, Mangesh Kritya, et al.
Circulation|August 21, 2002
Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernationSarah Shimoni, Nikolaos G Frangogiannis, Constadina J Aggeli, et al.
Circulation|November 22, 2000
Altered adrenergic receptor density in myocardial hibernation in humans: A possible mechanism of depressed myocardial functionK Shan, R J Bick, B J Poindexter, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 20, 2022
Site-Level Variation and Predictors of Permanent Pacemaker Implantation Following TAVR in the Evolut Low-Risk TrialHemal Gada, Amit N Vora, Gilbert H L Tang, et al.
The American Journal of Cardiology|June 12, 2023
Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial)Kees H van Bergeijk, Joanna J Wykrzykowska, Nicolas M van Mieghem, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2019
The train has left: Can surgeons still get a ticket to treat structural heart disease?Tom C Nguyen, Gilbert H L Tang, Stephanie Nguyen, et al.
JTCVS Open|July 17, 2024
Current definitions of hemodynamic structural valve deterioration after bioprosthetic aortic valve replacement lack consistencyBart J J Velders, Michiel D Vriesendorp, Federico M Asch, et al.
JTCVS Open|January 11, 2024
The robustness of the flow-gradient classification of severe aortic stenosisBart J J Velders, Michiel D Vriesendorp, Federico M Asch, et al.
American Heart Journal|December 11, 2017
Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trialSuzanne J Baron, Suzanne V Arnold, Matthew R Reynolds, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 18, 2025
Tricuspid Transcatheter Edge-to-Edge Repair Versus Medical Management for Tricuspid Regurgitation: A Systematic Review and Meta-AnalysisMangesh Kritya, Chloe Kharsa, Sahar Samimi, et al.
Pageof 56

Showing results (371-380 of 558) with videos related to

Sort By:
Pageof 56
JACC. Case Reports|June 25, 2026
Redo Transcatheter Aortic Valve Replacement for Degenerated Valve With High-Risk Coronary AnatomyChloe Kharsa, Gal Sella, Mangesh Kritya, et al.
Circulation|August 21, 2002
Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernationSarah Shimoni, Nikolaos G Frangogiannis, Constadina J Aggeli, et al.
Circulation|November 22, 2000
Altered adrenergic receptor density in myocardial hibernation in humans: A possible mechanism of depressed myocardial functionK Shan, R J Bick, B J Poindexter, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 20, 2022
Site-Level Variation and Predictors of Permanent Pacemaker Implantation Following TAVR in the Evolut Low-Risk TrialHemal Gada, Amit N Vora, Gilbert H L Tang, et al.
The American Journal of Cardiology|June 12, 2023
Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial)Kees H van Bergeijk, Joanna J Wykrzykowska, Nicolas M van Mieghem, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2019
The train has left: Can surgeons still get a ticket to treat structural heart disease?Tom C Nguyen, Gilbert H L Tang, Stephanie Nguyen, et al.
JTCVS Open|July 17, 2024
Current definitions of hemodynamic structural valve deterioration after bioprosthetic aortic valve replacement lack consistencyBart J J Velders, Michiel D Vriesendorp, Federico M Asch, et al.
JTCVS Open|January 11, 2024
The robustness of the flow-gradient classification of severe aortic stenosisBart J J Velders, Michiel D Vriesendorp, Federico M Asch, et al.
American Heart Journal|December 11, 2017
Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trialSuzanne J Baron, Suzanne V Arnold, Matthew R Reynolds, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 18, 2025
Tricuspid Transcatheter Edge-to-Edge Repair Versus Medical Management for Tricuspid Regurgitation: A Systematic Review and Meta-AnalysisMangesh Kritya, Chloe Kharsa, Sahar Samimi, et al.
Pageof 56